
XERS: Diamond Hands or Paper Losses? Analyst Day Filing Reveals Explosive Growth Trajectory.
Xeris Biopharma’s Analyst Day: $1 Billion in Revenue? Don’t Mind If I Do! Welcome back to your regularly scheduled programming on all things Xeris Biopharma...